Emily Marine Leproust Ph.D.
Net Worth

Last updated:

What is Emily Marine Leproust Ph.D. net worth?

The estimated net worth of Dr. Emily Marine Leproust Ph.D. is at least $48,173,299 as of 6 Dec 2024. He owns shares worth $19,183,582 as insider, has earned $22,589,717 from insider trading and has received compensation worth at least $6,400,000 in Twist Bioscience Corporation.

What is the salary of Emily Marine Leproust Ph.D.?

Dr. Emily Marine Leproust Ph.D. salary is $1,280,000 per year as Co-Founder, Chairman, Pres & Chief Executive Officer in Twist Bioscience Corporation.

How old is Emily Marine Leproust Ph.D.?

Dr. Emily Marine Leproust Ph.D. is 52 years old, born in 1973.

What stocks does Emily Marine Leproust Ph.D. currently own?

As insider, Dr. Emily Marine Leproust Ph.D. owns shares in one company:

Company Title Shares Price per share Total value
Twist Bioscience Corporation (TWST) Co-Founder, Chairman, Pres & Chief Executive Officer 674,718 $28.43 $19,183,582

What does Twist Bioscience Corporation do?

Twist Bioscience Corporation, a synthetic biology company, manufactures and sells synthetic DNA-based products. The company's DNA synthesis platform enables the manufacturing of synthetic DNA by writing DNA on a silicon chip. It offers synthetic DNA-based products, including synthetic genes, tools for sample preparation, antibody libraries for drug discovery and development, and DNA as a digital data storage medium. The company has collaboration agreements with Victorian Clinical Genetic Services; Vivlion GmbH.; Kyowa Kirin Pharmaceutical Research, Inc.; deepCDR Biologics AG; and Centogene N.V to develop advanced sequencing tools. It also has a research collaboration with Boehringer Ingelheim International GmbH to use proprietary antibody libraries to discover therapeutic antibodies against multiple targets. Twist Bioscience Corporation was incorporated in 2013 and is headquartered in South San Francisco, California.

TWST logo
TWST
Twist Bioscience Corporation
$28.43

Emily Marine Leproust Ph.D. insider trading

Twist Bioscience Corporation

Dr. Emily Marine Leproust Ph.D. has made 66 insider trades between 2020-2024, according to the Form 4 filled with the SEC. Most recently he sold 2,216 units of TWST stock worth $116,792 on 6 Dec 2024.

The largest trade he's ever made was exercising 96,518 units of TWST stock on 4 Sep 2020. As of 6 Dec 2024 he still owns at least 674,718 units of TWST stock.

Transaction Date Security Shares Price per share Total value Source
Sale
Common Stock 2,216 $52.7 $116,792
Sale
Common Stock 7,968 $48 $382,448
Sale
Common Stock 14,334 $44.61 $639,368
Sale
Common Stock 4,841 $41.56 $201,211
Sale
Common Stock 13,605 $43.21 $587,886
Sale
Common Stock 1,730 $46.94 $81,208
Sale
Common Stock 2,340 $39.16 $91,637
Sale
Common Stock 5,139 $39.93 $205,180
Sale
Common Stock 1,114 $48 $53,474
Sale
Common Stock 1,732 $49.41 $85,578
Sale
Common Stock 2,408 $51.33 $123,600
Sale
Common Stock 4,163 $37.13 $154,589
Sale
Common Stock 1,132 $32.74 $37,057
Sale
Common Stock 1,128 $33.52 $37,806
Sale
Common Stock 1,487 $37.43 $55,658
Option
Employee Stock Option (right to buy) 24,360 $5.95 $144,942
Option
Common Stock 24,360 $5.95 $144,942
Option
Common Stock 286 $8.82 $2,523
Option
Employee Stock Option (right to buy) 286 $8.82 $2,523
Sale
Common Stock 286 $60.03 $17,169
Option
Employee Stock Option (right to buy) 22,881 $7.39 $168,976
Option
Common Stock 22,881 $7.39 $168,976
Sale
Common Stock 5,300 $81.81 $433,582
Option
Employee Stock Option (right to buy) 6,960 $5.95 $41,412
Sale
Common Stock 6,960 $85.32 $593,841
Option
Common Stock 6,960 $5.95 $41,412
Option
Common Stock 10,440 $5.95 $62,118
Option
Employee Stock Option (right to buy) 10,440 $5.95 $62,118
Sale
Common Stock 10,440 $115.21 $1,202,782
Option
Common Stock 1,501 $8.82 $13,239
Option
Employee Stock Option (right to buy) 9,709 $8.82 $85,633
Sale
Common Stock 1,501 $139.39 $209,218
Option
Common Stock 8,208 $8.82 $72,395
Sale
Common Stock 8,208 $138.77 $1,139,041
Option
Common Stock 10,804 $7.39 $79,788
Sale
Common Stock 13,208 $131.8 $1,740,748
Option
Employee Stock Option (right to buy) 19,670 $7.86 $154,665
Option
Common Stock 8,866 $8.82 $78,198
Sale
Common Stock 9,166 $129.48 $1,186,786
Option
Employee Stock Option (right to buy) 1,740 $5.95 $10,353
Option
Common Stock 1,740 $5.95 $10,353
Sale
Common Stock 1,740 $120.99 $210,526
Sale
Common Stock 1,740 $110.16 $191,682
Option
Employee Stock Option (right to buy) 1,740 $5.95 $10,353
Option
Common Stock 1,740 $5.95 $10,353
Option
Employee Stock Option (right to buy) 8,700 $5.95 $51,765
Sale
Common Stock 1,740 $100.91 $175,589
Option
Common Stock 1,740 $5.95 $10,353
Sale
Common Stock 6,960 $97.8 $680,702
Option
Common Stock 6,960 $5.95 $41,412
Option
Common Stock 13,920 $5.95 $82,824
Option
Common Stock 13,920 $118.32 $1,646,945
Sale
Common Stock 13,920 $118.32 $1,646,945
Sale
Common Stock 13,920 $5.95 $82,824
Option
Employee Stock Option (right to buy) 13,920 $26.66 $371,107
Sale
Employee Stock Option (right to buy) 15,667 $26.66 $417,682
Option
Common Stock 15,667 $119.04 $1,864,937
Option
Employee Stock Option (right to buy) 15,667 $26.66 $417,682
Option
Employee Stock Option (right to buy) 15,667 $26.66 $417,682
Sale
Common Stock 15,667 $8.82 $138,183
Sale
Common Stock 6,329 $115.79 $732,854
Option
Common Stock 30,011 $7.39 $221,631
Sale
Common Stock 30,011 $109.69 $3,291,937
Option
Employee Stock Option (right to buy) 30,011 $7.39 $221,631
Option
Common Stock 9,530 $26.66 $254,070
Option
Employee Stock Option (right to buy) 9,530 $26.66 $254,070
Sale
Common Stock 32,362 $108.36 $3,506,649
Sale
Common Stock 2,000 $121.48 $242,968
Sale
Common Stock 2,000 $127.38 $254,756
Sale
Common Stock 2,000 $127.38 $254,756
Sale
Common Stock 2,000 $127.38 $254,756
Sale
Common Stock 2,000 $113.94 $227,870
Sale
Common Stock 2,000 $95.19 $190,372
Sale
Common Stock 2,000 $129.35 $258,694
Sale
Common Stock 2,000 $55.71 $111,422
Sale
Common Stock 2,000 N/A N/A
Sale
Common Stock 2,000 N/A N/A
Sale
Common Stock 75,000 N/A N/A
Sale
Common Stock 5,000 N/A N/A
Sale
Common Stock 20,000 N/A N/A
Sale
Common Stock 10,000 N/A N/A
Sale
Common Stock 2,000 N/A N/A
Sale
Common Stock 2,000 $170.95 $341,890
Option
Common Stock 5,300 N/A N/A
Option
Employee Stock Option (right to buy) 5,300 N/A N/A
Sale
Common Stock 5,000 N/A N/A
Sale
Common Stock 5,000 N/A N/A
Sale
Common Stock 10,000 N/A N/A
Sale
Common Stock 2,000 N/A N/A
Sale
Common Stock 70,000 N/A N/A
Sale
Common Stock 3,482 N/A N/A
Sale
Common Stock 96,518 N/A N/A
Sale
Common Stock 14,000 N/A N/A
Sale
Common Stock 15,000 N/A N/A
Sale
Common Stock 19,700 N/A N/A
Sale
Common Stock 300 N/A N/A
Sale
Common Stock 24,500 N/A N/A
Sale
Common Stock 10,593 N/A N/A
Sale
Common Stock 14,513 N/A N/A
Sale
Common Stock 14,438 N/A N/A
Sale
Common Stock 40,956 N/A N/A

Twist Bioscience key executives

Twist Bioscience Corporation executives and other stock owners filed with the SEC: